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Vitamin D Receptor Interactions and Genetic Variants in the Context of
Type 2 Diabetes Mellitus
Fatme Al Anouti*
Natural Science and Public Health Department, Zayed University, Abu Dhabi, UAE

Introduction
About 90% of diabetic patients around the world have type 2
diabetes mellitus according to the World Health Organization.A
significant proportion of the health care system resources worldwide
are devoted to cover diagnosis, treatment and management of type 2
diabetes [1]. Moreover, it is associated with morbidity like blindness,
renal failure and mortality. Type 2 diabetesis a progressive chronic
disease which is marked by the inability of tissues like liver and skeletal
muscles to respond to the hormone insulin which is secreted by the
pancreas. Several risk factors like genetics, environmental factors and
obesity contribute to the development of type 2 diabetes. Studies on
genes which predispose to type 2 diabeteshave been conducted by
various researchers among different ethnic populations. Genome
wide association studies have led to the identification of many single
nucleotide polymorphisms in certain genes and linked them to type 2
diabetes [2,3]. Recently, genes involved in vitamin D metabolism have
gained interest because of the association between vitamin D deficiency
and type 2 diabetes. High vitamin D levels were significantly associated
with reduced risk for type 2 diabetes among Australian adult men
and [4]. Vitamin D deficiency results in reduced insulin secretion in
humans and rats, and its supplementation improves glucose tolerance
[5]. One major study has suggested that vitamin D supplementation
could lead to a significant reduction in mortality [6]. In addition,
vitamin D is required for absorption of dietary calcium. Calcium is
essential for insulin-mediated processes in insulin responsive tissues.
Calcium repletion normalizes glucose tolerance and secretion of insulin
in vitamin D-depleted rats and hypocalcemia in nondiabetics reduces
insulin secretion [4].

Vitamin D and Vitamin D Receptor Interactions
Vitamin D deficiency has become an insidious epidemic among all age
groups in many parts of the world. Recent discoveries have documented
a protective role for vitamin D in the case of several chronic morbidities
like osteoporosis, cancer, diabetes, and cardio-vascular diseases [7].
Maintaining a good vitamin D status requires adequate exposure to UV
or sufficient intake from diet and supplements. Biomarkers of vitamin D
status are also affected by season and geographic latitude [8]. However,
variability is also attributable to genetic factors which can affect by as
high as 53% [9]. Elucidations about the role of common genetic variants
on vitamin D status has recently started to emanate [10]. Candidate
gene studies are important to examine the effect of specific vitamin D
pathway genes on other diseases and to assess the influence of genetic
variation on vitamin D status.Most of what is understood about the
beneficial effects of vitamin D relate to the important role of the vitamin
D receptor (VDR) protein as a transcription factor, although various
non-genomic actions of the VDR have also been identified. The VDR is
expressed in many tissues throughout the body and modulates a variety
of physiological processes, including aspects of calcium homeostasis
that affect both bone formation and calcium-dependent signaling, and
lipid metabolism [4-7].

Vitamin D Receptor Variants
Some of the genetic determinants for vitamin D status include
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the VDR gene which is particularly a good candidate for disease
susceptibility, because of its involvement in insulin metabolism [11,12].
Several research studies have focused on the association between VDR
genetic polymorphisms in the context of vitamin D deficiency and type
2 diabetes. Among these polymorphisms, Fok I, Taq I, Bsm I, EcoR
V and Apa I are all suspected to alter the activity of the VDR protein
and modulate susceptibility to type 2 diabetes. Vitamin D regulates
the expression of the insulin receptor gene, and insulin secretion by
binding VDR [5]. Vitamin D regulates the expression of the insulin
receptor gene, and insulin secretion by binding VDR. This cytosolic/
nuclear receptor acts as a transcriptional factor for many genes. VDR
gene is an interesting candidate for type 2 diabetes pathogenesis and
clinical manifestations. This gene is located on chromosome 12q13.1
and consists of 14 exons.VDR is expressed in many tissues involved in
the regulation of glucose metabolism such as muscles and pancreatic
cells. Once it binds vitamin D, it undergoes a conformational change
that facilitates its binding to retinoid X forming a heterodimer which in
turn interacts with the vitamin D responsive elements in the promoter
region of target genes, hence modifying their expression [11-13].
Findings from a research study indicated that VDR polymorphism
in exon 9 (Taq I) and intron 8 (Bsm I) were significantly associated
with type 2 diabetes among Caucasian Americans from European
origin [14,10]. Moreover, the metabolic parameters which characterize
type 2 diabetes including dyslipidemia, hypertriglyceridemia, and low
HDL levels were correlated with the reported VDR polymorphism.
The results were in concordance with another research conducted in
Saudi Arabia [15]. Other researchers failed to demonstrate a similar
link among Indians, Turkish and Polish Populations [3,16]. This
discrepancy in findings from different studies is attributed in fact to
the differences in population genetics. Examining population-based
genetic association between VDR variants and type 2 diabetes could of
extreme importance for a specific population that has a high prevalence
of both type 2 diabetes and VTD deficiency like that of the United Arab
Emirates [17]. Such studies could direct future strategies for prevention
and treatment of type 2 diabetesby designing new more relevant
population-based interventions which can specifically and effectively
target “high risk individuals”.

Conclusion
Genetics plays a complex role in the pathogenesis of both vitamin
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D deficiency and type 2 diabetes. Genome wide studies have led to
the identification of several genetic variants which are associated
with certain diseases like type 2 diabetes mellitus. These variants
are often population-based determinants which could predispose a
particular ethnicity to a certaindisease, hence significantly increasing
its prevalence. The VDR primarily acts as a transcription factor–
controlling the amounts of certain proteins that are produced from
the DNA in the genetic code. The proteins produced by the DNA that
the VDR targets are responsible for processes from inflammation to
lipid storage and calcium regulation, and deficiencies in vitamin D
are associated with many diseases, particularly type 2 diabetes. The
VDR also has several non-DNA-related actions, but these are generally
much less well understood than the genomic effects. Studies which
aim to characterize the interaction of the VDR and its ligand would
be informative. Model membranes which mimic the composition of
sphingolipid- and cholesterol-rich microdomainsact as a model of
‘normal’ VDR-membrane interactions. Examining the interaction
of vitamin D with such models could help identify the factors that
modulate these interactions and develop a better understanding of
the mechanisms of VDR-related pathogenesis in several disorders
including type 2 diabetes.
The DNA sequences of the human genome have revealed that
many genes are polymorphic. In coding or non-coding regions of
a specific gene, there may be either a single base pair substitution of
one nucleotide for another or a variable number of repeats of a short,
repetitive DNA sequences. These variations may influence the rate of
gene transcription, the stability of the messenger RNA or the quantity
and activity of the resulting protein. Thus the susceptibility or severity
of a number of disorders will be influenced by possession of specific
alleles of polymorphic genes. The polymorphic many genes that have
received a great deal of research interest such as PPARG2, TCF7L2, and
FTO because of their association with diabetes.
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